Filing Details
- Accession Number:
- 0001127602-23-017113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-30 20:16:57
- Reporting Period:
- 2023-05-30
- Accepted Time:
- 2023-05-30 20:16:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1813312 | Todd Christian Nichols | 852 Winter St. Waltham MA 02451 | Svp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2023-05-30 | 19,634 | $20.43 | 68,118 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2023-05-30 | 27,134 | $28.93 | 40,984 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2023-05-30 | 19,634 | $0.00 | 19,634 | $20.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
44,327 | 2030-02-20 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/2023.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.56 to $29.19. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
- Shares subject to the stock option award vest and become exercisable in four equal annual installments commencing on 2/20/2021.